A German, non-Interventional study of NEPA (fixed dose Netupitant/Palonosetron) for the prevention of chemotherapy induced nausea and vomiting

Trial Profile

A German, non-Interventional study of NEPA (fixed dose Netupitant/Palonosetron) for the prevention of chemotherapy induced nausea and vomiting

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Jan 2017

At a glance

  • Drugs Netupitant/palonosetron (Primary)
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2017 New trial record
    • 06 Dec 2016 First results (n=583) presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top